MediWound (MDWD)
(Delayed Data from NSDQ)
$17.70 USD
+1.35 (8.26%)
Updated Aug 8, 2024 04:00 PM ET
After-Market: $17.73 +0.03 (0.17%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
MediWound Ltd. [MDWD]
Reports for Purchase
Showing records 21 - 38 ( 38 total )
Company: MediWound Ltd.
Industry: Medical - Drugs
Company: MediWound Ltd.
Industry: Medical - Drugs
Company: MediWound Ltd.
Industry: Medical - Drugs
Company: MediWound Ltd.
Industry: Medical - Drugs
EscharEx Development Continues; NexoBrid CRL Re-submission in Early 2022; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
Promising Pediatric Data; Potential for EU Label Expansion; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
Company: MediWound Ltd.
Industry: Medical - Drugs
Potential Delay of NexoBrid Approval is Not Ominous; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
Awaiting NexoBrid Approval; Multiple Clinical Updates Expected; Higher $7 PT; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
Eyes on NexoBrid Regulatory Decision; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
Expect NexoBrid Approval in June 2021; Vericel to Host an Investor Day in October
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
BARDA Procurement Begins in 3Q20; Catalyst Rich 2021; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
NexoBrid, One Step Closer to Approval; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
NexoBrid BLA Submission Remains on Track; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
Another Eventful Year Expected With BLA Submission in Mid-2020; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
BARDA Contract Bodes Well for BLA Approval; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
Company: MediWound Ltd.
Industry: Medical - Drugs
NexoBrid BLA to Be Filed in 2Q20; EscharEx Phase 2 Study Start in 4Q19; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: MediWound Ltd.
Industry: Medical - Drugs
Developing a Novel, Expandable Wound Care Platform; Initiate With Buy and $5.50 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S